Research identifies successful new treatment for Hodgkin's lymphoma, reduces long-term risks

PROVIDENCE, RI -- New research led by Cindy Schwartz, MD, of Hasbro Children's Hospital has identified a new chemotherapy regimen for pediatric Hodgkin lymphoma (HL) patients. The new treatment enhances efficacy through dose-dense drug delivery while simultaneously reducing the long-term risks presented by high cumulative dose chemotherapy.

Read the whole article on Science Blog

More from Science Blog